Search

Your search keyword '"Thomas, Clayton"' showing total 707 results

Search Constraints

Start Over You searched for: Author "Thomas, Clayton" Remove constraint Author: "Thomas, Clayton"
707 results on '"Thomas, Clayton"'

Search Results

1. Revisiting the Primitives of Transaction Fee Mechanism Design

2. Describing Deferred Acceptance and Strategyproofness to Participants: Experimental Analysis

3. Communication Separations for Truthful Auctions: Breaking the Two-Player Barrier

4. Priority-Neutral Matching Lattices Are Not Distributive

6. 'Yet in His Idle Fire:' Once More unto the Bertram and All’s Well

7. Structural Complexities of Matching Mechanisms

8. Strategyproofness-Exposing Mechanism Descriptions

9. Exponential Communication Separations between Notions of Selfishness

10. Classification of Priorities Such That Deferred Acceptance is Obviously Strategyproof

11. Tiered Random Matching Markets: Rank is Proportional to Popularity

12. Representing All Stable Matchings by Walking a Maximal Chain

13. The Short-Side Advantage in Random Matching Markets

14. Implementation in Advised Strategies: Welfare Guarantees from Posted-Price Mechanisms when Demand Queries are NP-hard

20. Iran: Background and U.S. Policy.

21. Afghanistan: Background and U.S. Policy.

23. Israel and Lebanese Hezbollah: Conflict and Escalation.

24. Advertising and integrated brand promotion.

30. Lebanese Hezbollah.

31. Abnormal movements and diaphragmatic flutter in a case of suspected induced illness

32. Supplementary Table S1 from Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic Malignancies

33. Supplementary Data from Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic Malignancies

34. Data from Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic Malignancies

42. Israel and Hamas October 2023 Conflict: Frequently Asked Questions (FAQs).

44. CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells

48. Crystal structure of the SALL4–pomalidomide–cereblon–DDB1 complex

49. Factors influencing outcome following severe musculo-skeletal traumatic injury

50. Iran: Background and U.S. Policy.

Catalog

Books, media, physical & digital resources